is there a patent on semaglutide Novo Nordisk expiry opens door to cheaper weight-loss drugs in India A Snapshot of the Semaglutide

Semaglutide has demonstrated the highest percentage of weight loss in obese adults without type 2 diabetes, with reductions of approximately 15% of initial weight at 68 weeks (Wilding et al., 2021)

Hypersensitivity reactions, including anaphylaxis and angioedema, have been reported and require immediate medical attention and drug discontinuation

For a 39-amino-acid peptide like retatrutide, even small sequence errors can dramatically alter biological activity

10.1016/j.ejca.2018.01.065 Eur

Los estudios muestran que la retirada abrupta sin soporte conductual conlleva a la recuperacin de gran parte del peso perdido

The combination of both medications typically achieves greater glucose improvements and weight loss than either drug used separately, making dual therapy a clinically supported approach for many people